Aristotle Capital Boston LLC Cuts Stock Position in Itron, Inc. $ITRI

Aristotle Capital Boston LLC cut its holdings in Itron, Inc. (NASDAQ:ITRI) by 28.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 303,560 shares of the scientific and technical instruments company’s stock after selling 123,119 shares during the quarter. Itron comprises 1.9% of Aristotle Capital Boston LLC’s holdings, making the stock its 10th biggest position. Aristotle Capital Boston LLC’s holdings in Itron were worth $37,812,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. DLD Asset Management LP lifted its stake in Itron by 49.9% in the third quarter. DLD Asset Management LP now owns 63,400 shares of the scientific and technical instruments company’s stock valued at $7,897,000 after buying an additional 21,100 shares in the last quarter. Campbell & CO Investment Adviser LLC bought a new stake in shares of Itron during the third quarter worth $1,300,000. Robeco Schweiz AG increased its position in shares of Itron by 31.2% during the third quarter. Robeco Schweiz AG now owns 372,176 shares of the scientific and technical instruments company’s stock worth $46,358,000 after acquiring an additional 88,504 shares in the last quarter. Schroder Investment Management Group raised its holdings in shares of Itron by 23.6% during the second quarter. Schroder Investment Management Group now owns 376,087 shares of the scientific and technical instruments company’s stock worth $49,504,000 after acquiring an additional 71,702 shares during the period. Finally, J. Safra Sarasin Holding AG acquired a new stake in shares of Itron during the third quarter worth $4,673,000. 96.19% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts recently weighed in on ITRI shares. Wall Street Zen lowered shares of Itron from a “buy” rating to a “hold” rating in a research note on Wednesday, January 14th. Oppenheimer lifted their price target on Itron from $125.00 to $133.00 and gave the company an “outperform” rating in a research note on Wednesday, February 18th. Guggenheim set a $155.00 price target on Itron in a report on Friday, February 13th. Robert W. Baird set a $128.00 price objective on Itron and gave the stock an “outperform” rating in a research report on Wednesday, February 18th. Finally, Needham & Company LLC began coverage on Itron in a report on Friday, March 6th. They set a “buy” rating and a $124.00 price objective for the company. Eight analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $137.10.

Itron Price Performance

Shares of NASDAQ ITRI opened at $90.00 on Friday. The stock has a market capitalization of $4.04 billion, a price-to-earnings ratio of 13.82, a PEG ratio of 0.78 and a beta of 1.44. The business has a 50-day moving average of $97.33 and a 200-day moving average of $106.71. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.80 and a quick ratio of 1.56. Itron, Inc. has a fifty-two week low of $88.57 and a fifty-two week high of $142.00.

Itron (NASDAQ:ITRI) last released its earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.19 by $0.27. Itron had a return on equity of 20.04% and a net margin of 12.72%.The business had revenue of $571.66 million for the quarter, compared to analyst estimates of $561.31 million. During the same quarter in the prior year, the company posted $1.35 earnings per share. Itron’s revenue was down 6.7% on a year-over-year basis. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. As a group, sell-side analysts predict that Itron, Inc. will post 5.33 earnings per share for the current fiscal year.

Insider Activity

In other Itron news, CFO Joan S. Hooper sold 15,293 shares of the business’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $99.54, for a total transaction of $1,522,265.22. Following the transaction, the chief financial officer owned 124,196 shares of the company’s stock, valued at $12,362,469.84. The trade was a 10.96% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Christopher E. Ware sold 4,486 shares of the company’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $99.54, for a total value of $446,536.44. Following the sale, the senior vice president owned 31,806 shares in the company, valued at approximately $3,165,969.24. This represents a 12.36% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 51,180 shares of company stock worth $5,085,475. Corporate insiders own 1.45% of the company’s stock.

Itron Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.